126 related articles for article (PubMed ID: 27352323)
1. Treatment of Benign Prostatic Hyperplasia by Ultrasound-Guided Botulinum Toxin Type A Injection.
Ding XD; Chen HX; Xiao HQ; Wang W; Ding ZG; Zhang GB; Fu DG
Cell Biochem Biophys; 2015 Nov; 73(2):357-359. PubMed ID: 27352323
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
[TBL] [Abstract][Full Text] [Related]
3. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
[TBL] [Abstract][Full Text] [Related]
4. Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia.
Chuang YC; Chiang PH; Yoshimura N; De Miguel F; Chancellor MB
BJU Int; 2006 Nov; 98(5):1033-7; discussion 1337. PubMed ID: 16956361
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of add-on botulinum toxin A on patients with large benign prostatic hyperplasia and unsatisfactory response to combined medical therapy.
Kuo HC; Liu HT
Scand J Urol Nephrol; 2009; 43(3):206-11. PubMed ID: 19308807
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates.
Chuang YC; Chiang PH; Huang CC; Yoshimura N; Chancellor MB
Urology; 2005 Oct; 66(4):775-9. PubMed ID: 16230137
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia.
Park DS; Cho TW; Lee YK; Lee YT; Hong YK; Jang WK
Yonsei Med J; 2006 Oct; 47(5):706-14. PubMed ID: 17066515
[TBL] [Abstract][Full Text] [Related]
8. Effect of onabotulinum toxin type a intraprostatic injection on the outcome of Benign Prostatic Hyperplasia patients refractory to medical therapy: A 2-year follow-up study.
Rodrigues de Carvalho TG; Pinto R; Cruz F; Silva J
Arch Esp Urol; 2016 Dec; 69(10):719-726. PubMed ID: 28042794
[TBL] [Abstract][Full Text] [Related]
9. Intraprostatic botulinum toxin type A injection for the treatment of benign prostatic hyperplasia: Initial experience with Dysport.
Nikoobakht M; Daneshpajooh A; Ahmadi H; Namdari F; Rezaeidanesh M; Amini S; Pourmand G
Scand J Urol Nephrol; 2010 Apr; 44(3):151-7. PubMed ID: 20201752
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A injection to the bladder neck and urethra for medically refractory lower urinary tract symptoms in men without prostatic obstruction.
Chen JL; Chen CY; Kuo HC
J Formos Med Assoc; 2009 Dec; 108(12):950-6. PubMed ID: 20040460
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ultrasound-guided transrectal ethanol injection for the treatment of benign prostatic hyperplasia in patients with high-risk comorbidities: a long-term study at a single tertiary care institution.
Li Y; Zhao Q; Dong L
Urology; 2014 Mar; 83(3):586-91. PubMed ID: 24581519
[TBL] [Abstract][Full Text] [Related]
12. Intraprostatic botulinum neurotoxin type a injection for benign prostatic hyperplasia: preliminary results with a newly purified neurotoxin.
Yokoyama T; Yamamoto Y; Suzuki T; Oguma K; Nagai A
Acta Med Okayama; 2012; 66(4):291-7. PubMed ID: 22918201
[TBL] [Abstract][Full Text] [Related]
13. [Effects of intraprostatic injection of botulinum toxin A (BTX-A) on benign prostate hyperplasia].
Xu YP; Yu X; Ye ZQ; Pan TJ; Wen HD; Wang T
Zhonghua Nan Ke Xue; 2010 Oct; 16(10):905-10. PubMed ID: 21243754
[TBL] [Abstract][Full Text] [Related]
14. Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement. Effect on prostate volume and micturition resumption.
Silva J; Silva C; Saraiva L; Silva A; Pinto R; Dinis P; Cruz F
Eur Urol; 2008 Jan; 53(1):153-9. PubMed ID: 17825981
[TBL] [Abstract][Full Text] [Related]
15. Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment.
Silva J; Pinto R; Carvalho T; Botelho F; Silva P; Oliveira R; Silva C; Cruz F; Dinis P
BMC Urol; 2009 Aug; 9():9. PubMed ID: 19682392
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of botulinum toxin injection for benign prostatic hyperplasia: a systematic review and meta-analysis.
Shim SR; Cho YJ; Shin IS; Kim JH
Int Urol Nephrol; 2016 Jan; 48(1):19-30. PubMed ID: 26560471
[TBL] [Abstract][Full Text] [Related]
17. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study.
Maria G; Brisinda G; Civello IM; Bentivoglio AR; Sganga G; Albanese A
Urology; 2003 Aug; 62(2):259-64; discussion 264-5. PubMed ID: 12893330
[TBL] [Abstract][Full Text] [Related]
18. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.
Kuo HC
Urology; 2005 Apr; 65(4):670-4. PubMed ID: 15833506
[TBL] [Abstract][Full Text] [Related]
19. Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs.
Chuang YC; Tu CH; Huang CC; Lin HJ; Chiang PH; Yoshimura N; Chancellor MB
BMC Urol; 2006 Apr; 6():12. PubMed ID: 16620393
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin type A for the treatment of benign prostatic hyperplasia: randomized study comparing two doses.
Arnouk R; Suzuki Bellucci CH; Benatuil Stull R; de Bessa J; Malave CA; Mendes Gomes C
ScientificWorldJournal; 2012; 2012():463574. PubMed ID: 22997495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
